TIC Solutions walked into its Q1 2026 earnings call today carrying one of the sharpest short-interest buildups of the past month — and the results handed both sides something to argue about.
Short sellers added positions aggressively in the runup to today's print. Short interest climbed from roughly 16% of the free float on April 24 to 21.6% by May 5 — a move of more than five percentage points in eight trading sessions. That is a meaningful acceleration. As recently as mid-April, SI had traded in the 15–16% range for over two weeks before the selling conviction reset sharply higher. The ORTEX short score reflects this shift, running at 74.3 — a reading that puts TIC in the top tier of short-side pressure across the exchange.
The borrow market tells the same story, but with added texture. Availability — the ratio of shares still available to borrow against those already lent out — compressed from a relaxed 244% in late April to 96% by Tuesday. That is a halving in less than two weeks. At 96%, the borrow pool is tighter than at any point in the visible history here. It is not a squeeze in the classic sense — there is still roughly one share available for each already borrowed — but the direction of travel is clear. Cost to borrow, at just under 0.5%, has not repriced yet, suggesting the tightening in availability reflects genuine demand for shorts rather than a supply withdrawal by lenders. If availability continues compressing below the 50% threshold, borrowing costs would typically follow.
The earnings print complicates the short thesis. Q1 revenue of $488M beat the $475M consensus estimate by more than 2.5%. EPS of -$0.19 missed the -$0.12 estimate, but management reiterated full-year 2026 sales guidance of $2.15B–$2.25B — bracketing the Street's $2.18B estimate squarely. The revenue beat and unchanged guidance are the headline facts shorts were positioned against. The stock had already rallied 37% over the past month before the print, rising 7% on the week alone, so some of the good news was in the price. The one prior earnings reaction on record — March 27 — saw the stock fall 6% the day after the release before recovering almost entirely over the following five days.
Analyst coverage is thin and the most recent moves are now roughly six weeks old. JP Morgan downgraded to Underweight with a $7 target in late March, while UBS cut its target to $8. Roth Capital initiated at Buy with a $10 target around the same time. The mean price target across the small coverage universe lands at $10.14, just above Tuesday's close of $9.50. With the stock having run 37% in a month, the small cluster of analysts is no longer offering much of a premium. Valuation has re-rated alongside the price: the P/E multiple expanded by more than five points over the past 30 days to roughly 19x, and the EV/EBITDA ratio edged above 9.7x. Neither extreme, but both moving in the direction that makes shorts more defensible on paper.
Ownership adds one more layer of interest. Martin Franklin disclosed a new position of 13.2 million shares — just under 6% of the company — as of April 24, making him the sixth-largest declared holder. Franklin's track record as an activist builder means his entry is the kind of event that forces short sellers to think twice. Permian Investment Partners also added 2.8 million shares in early April. Together, these two moves represent concentrated fresh buying that arrived precisely as the short-side was building.
The next scheduled catalyst is the Investor Day on May 19. With borrow availability tightening, a fresh high-profile holder on the register, and the earnings print producing a revenue beat alongside a guidance hold, that event will determine whether the recent short buildup was prescient — or premature.
See the live data behind this article on ORTEX.
Open TIC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
